Try our mobile app

General information

Country: UNITED STATES

Sector: Diagnostics and Research

Danaher Corporation designs, manufactures, and markets professional, medical, industrial and commercial products, and services in the sectors of test and measurement, environmental, life sciences, dental, and industrial technologies.
Website: danaher.com


  • Bad financial results growth rate -9.7% (average between last period year over year growth for revenue and EBITDA), there is slowdown compared to average historical growth rates (-3.9%)
  • Dividend yield for the last twelve months 0.3%
  • Free cash flow yield -0.6% (LTM)
  • Share price is 49.2% higher than minimum and 16.1% lower than maximum for the last 3 years
  • The company is overvalued by EV / LTM EBITDA multiple compared to target level (34.2x vs
    )
  • Fundamental value created in LTM (estimate)
  • For the last 3 months insiders sold company shares on $15.0 mln (-0.007% of cap.)

Key Financials (Download financials)

Ticker: DHR
Share price, USD:  (+0.7%)276.14
year average price 242.22  


year start price 253.77 2023-09-18

min close price 185.10 2023-10-30

max close price 280.76 2024-08-01

current price 274.25 2024-09-16
Common stocks: 727 076 992

Dividend Yield:  0.3%
FCF Yield LTM: -0.6%
EV / LTM EBITDA: 34.2x
EV / EBITDA annualized: 31x
Last revenue growth (y/y):  -19.8%
Last growth of EBITDA (y/y):  +0.3%
Historical revenue growth:  -1.3%
Historical growth of EBITDA:  -6.5%
Target EV / EBITDA (hist percentile):
Fundamental value created in LTM:
EV / LTM EBITDA mutiple calculation
Market Cap ($m): 200 775
Net Debt ($m): 12 542
EV (Enterprise Value): 213 317
EBITDA LTM ($m): 6 246
EV / LTM EBITDA: 34.2x
Price to Book: 4.0x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / EBITDA

Potential dynamics

News


2024-09-10prnewswire.com

Danaher Announces Quarterly Dividend

2024-09-10zacks.com

Here's Why It is Appropriate to Retain Danaher Stock For Now

2024-08-26prnewswire.com

Danaher to Webcast Diagnostics Investor & Analyst Meeting in Washington, D.C.

2024-08-22seekingalpha.com

Danaher: Lofty Price, Bright Future

2024-08-22zacks.com

Why Is Danaher (DHR) Up 2% Since Last Earnings Report?

2024-07-23zacks.com

Danaher (DHR) Q2 Earnings Beat, Biotechnology Sales Dip Y/Y

2024-07-23investopedia.com

Danaher Stock Soars on Q2 Earnings Beat

2024-07-23fool.com

Here's Why Danaher Stock Surged Today

2024-07-23barrons.com

Danaher Stock Surges. More Than Earnings Are Driving It Higher.

2024-07-19zacks.com

Will Danaher (DHR) Beat Estimates Again in Its Next Earnings Report?
More information for subscribed users:
detailed calculation of
Potential and Created Value,
website traffic data